Type I consensus IFN (IFN-con1) gene transfer-into KSHV/HHV-8-infected BCBL, 1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in SCID mice

Journal of Interferon and Cytokine Research

Volumn 19, Issue 11, 1999, Pages 1305-1316

  D'Agostino, Giuseppina ^a   Aricò, Eleonora ^a   Santodonato, Laura ^a   Venditti, Massimo ^a   Sestili, Paola ^a   Masuelli, Laura ^b   Coletti, Anna ^b   Modesti, Andrea ^c   Picchio, Gaston ^d   Mosier, Donald E ^d   Ferrantini, Maria ^a   Belardelli, Filippo ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; GENE TRANSFER; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS GENOME;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE; CELL TRANSPLANTATION; GENE TRANSFER TECHNIQUES; HELA CELLS; HERPESVIRUS 8, HUMAN; HUMANS; IN SITU NICK-END LABELING; INTERFERON TYPE I, RECOMBINANT; LYSOGENY; MALE; MICE; MICE, SCID; SARCOMA, KAPOSI; SEVERE COMBINED IMMUNODEFICIENCY; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8;

EID: 0032748921     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099312984     Document Type: Article

References (48)

1. CHANG, Y., CESARMAN, E., PESSIN, M.S., LEE, F., CULPEPPER, J., KNOWLES, D.M., and MOORE, P. (1994). Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869.
2. BUONAGLRO, F.M., TORNESELLO, M.L., BETH-GIRALDO, E., HATZAKIS, A., MUELLER, N., DOWNING, R., BIRYAMWAHO, B., SEMPALA, S.D., and GIRALDO, G. (1996). Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int. J. Cancer 65, 25-28.
3. CHANG, Y., ZIEGLER, J., WABINGA, H., KATANGOLE-MBIDDE, E., BOSHOFF, C., SHULTZ, T., WHITBY, D., MADDALENA, D., JAFFE, H.W., WEISS, R.A., and MOORE, P.S. (1996). Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch. Intern. Med. 156, 202-204.
4. CHUCK, S., GRANT, R.M., KATANGOLE-MBIDDE, E., CONANT, M., and GANEM, D. (1996). Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J. Infect. Dis. 173, 248-251.
5. MOORE, P., and CHANG, Y. (1995). Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J. Med. 332, 1181-1185.
6. CESARMAN, E., CHANG, Y., MOORE, P.S., SAID, J.W., and KNOWLES, D.M. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332, 1186-1191.
7. SOULIER, J., GROLLET, L., OKSENHENDLER, E., CACOUB, P., CAZALS-HATEM, D., BABINET, P., D'AGAY, M.F., CLAUVEL, J.P., RAPHAEL, M., DEGOS, L., and SIGAUX, F. (1995). Kaposi's sarcoma-associated herpes virus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280.
8. BERAL, V. (1991). Epidemiology of Kaposi's sarcoma. Cancer 10, 5-22.
9. CARBONE, A., GLOGHINI, A., VACCHER, E., ZAGONEL, V., PASTORE, C. DALLA PALMA, P., BRANZ, F., SAGLIO, G., VOLPE, R., TIRELLI, U., and GAIDANO, G. (1996). Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br. J. Haematol. 94, 533-543.
10. NEIPEL, F., ALBRECHT, J.C., and FLECKENSTEIN, B. (1997). Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J. Virol. 71, 4187-4192.
11. RENNE, R., ZHONG, W., HERNDIER, B., McGRATH, M., ABBEY, N., KEDES, D., and GANEM, D. (1996). Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2, 342-346.
12. PICCHIO, G.R., SABBE, R.E., GULIZIA, R.J., McGRATH, M., HERNDIER, B.C., and MOSIER, D. (1997). The KSHV/HHV-8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology 238, 22-29.
13. KALVAKOLANU, D.V., and BORDEN, E.C. (1996). An overview of the interferon system: signal transduction and mechanisms of action. Cancer Invest. 14, 25-53.
14. GUTTERMAN, J.U. (1994). Cytokine therapeutics: lessons from interferon α. Proc. Natl. Acad. Sci. USA 91, 1198-1205.
15. EZEKOWITZ, R.A.B., MULLIKEN, J.B., and FOLKMAN, J. (1992). Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N. Engl. J. Med. 326, 1456-1463.
16. KROWN, S.E. (1998). Interferon-alpha: evolving therapy for AIDS-associated Kaposi's sarcoma. J. Interferon. Cytokine Res. 18, 209-214.
17. MARKOWITZ, D., GOFF, S., and BANK, A. (1988), A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J. Virol. 62, 1120-1124.
18. MARKOWITZ, D., GOFF, S., and BANK, A. (1988). Construction and use of a safe and efficient amphotropic packaging cell line. Virology 167, 400-406.
19. MILLER, A.D., and ROSSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980-984.
20. GENG, Y., YU, D., BLATT, L.M., and TAYLOR, M.W. (1995). Tumor suppressor activity of the human consensus type I interferon gene. Cytokines Mol. Ther. 1, 289-300.
21. ALTON, K., STABINSKY, Y., RICHARDS, R., FERGUSON, B., GOLDESTEIN, L., ALTROCK, B., MILLER, L., and STEBBINGS, N. (1983). Production, characterization and biological ef fects of recombinant DNA derived human IFN-α and IFN-γ analogs. In: The Biology of the Interferon System. E. De Maeyer and H. Schellenkens. (eds.) Amsterdam: Elsevier, pp. 119-128.
22. ZHANG, J.-F., HU, C., GENG, Y., SELM, J., KLEIN, S.B., ORAZI, A., and TAYLOR, M.W. (1996). Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy. Proc. Nad. Acad. Sci. USA 93, 4513-1518.
23. ROCHFORD, R., CANNON, M.J., SABBE, R.E., ADUSUMILLI, K., PICCHIO, G., GLYNN, J.M., NOONAN, D.J., MOSIER, D.E., and HOBBS, M.V. (1997). Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines. Viral Immunol. 10, 183-195.
24. RENNE, R., LAGUNOFF, M., ZHONG, W., and GANEM, D. (1996). The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 70, 8151-8154.
25. BENECH, P., MORY, Y., REVEL, M., and CHEBATH, J. (1985). Structure of two forms of the interferon-induced (2′-5′)oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J. 4, 2249-2256.
26. CAO, S.J., BOSHOFF, C., JAYACHANDRA, S., WEISS, R.A., CHANG, Y., and MOORE, P.S. (1997). KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene 15, 1979-1985.
27. ZIMRING, J.C., GOODBOURN, S., and OFFERMAN, M.K. (1998). Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J. Virol. 72, 701-707.
28. MONINI, P., CARLINI, F., STÜRZL, M., RIMESSI, P., SUPERTI, F., FRANCO, M., MELUCCI-VIGO, G., CAFARO, A., GOLETTI, D., SGARDARI, C., BUTTO', S., LEONE, P., LEONE, P., CHIOZZINI, C., BARRESI, C., TTNARI, A., BONACCORSI, A., CAPOBIANCHI, M.R., GIULIANL M., DI CARLO, A., ANDREONI, M., REZZA, G., and ENSOLI, B. (1999). Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J. Virol. 73, 4029-4041.
29. KUMAR, A., YANG, Y.L., FLATI, V., DER, S., KADEREIT, S., DEB, A., HAQUE, J., REIS, L., WEISSMANN, C., and WILLIAMS, B.R.G. (1997). Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-κB. EMBO J. 16, 406-416.
30. TANAKA, N., ISHIHARA, M., KITAGAWA, M., HARADA, H., KIMURA, T., MATSUYAMA, T., LAMPHIER, M.S., AIZAWA, S., MAK, T.W., and TANIGUCHI, T. (1994). Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77, 829-839.
31. ZHOU, A., PARANJAPE, J., BROWN, T.L., NIE, H., NAIK, S., DONG, B., CHANG, A., TRAPP, B., FAIRCHILD, R., COLMENARES, C., and SILVERMAN, R.H. (1997). Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate- dependent Rnase L. EMBO J. 16, 6355-6363.
32. CASTELLI, J.C., HASSEL, B.A., WOOD, K.A., LI, X.-L., AMAMIYA, K., DALAKAS, M.C., TORRENCE, P.P., and YOULE, R.J. (1997). A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J. Exp. Med. 186, 967-972.
33. TANAKA, N., SATO, M., LAMPHIER, M.S., NOZAWA, H., ODA, E., NOGUCHI, S., SCHREIBER, R.D., TSUJIMOTO, Y., and TANIGUICHI, T. (1998). Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells 3, 29-37.
34. DVORAK, H.F., and GRESSER, I. (1989). Microvascular injury in pathogenesis of IFN-induced necrosis of subcutaneous tumors in mice. J. Natl. Cancer. Inst. 81, 497-502.
35. THOMAS, H.T., and BALKWILL, F.R. (1992). Effects of interferons and other cytokines on tumors in animals: a review. Pharmacol. Ther. 52, 307-331.
36. SIDKY, Y.A., and BORDEN, E.C. (1987). Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res. 47, 5155-5161.
37. SINGH, R.K., GUTMAN, M., BUCANA, CD., SANCHEZ, R., LLANSSA, N., and FIDLER, I.J. (1995). Interferons α and β down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc. Natl. Acad. Sci. USA 92, 4562-4566.
38. NICKOLOFF, B.J., and FOREMAN, K.E. (1996). Charting a new course through the chaos of KS (Kaposi's sarcoma). Am. J. Pathol. 148, 1323-1329.
39. CORNALI, E., ZIETZ, C., BENELLI, R., WENINGER, W., MASIELLO, L., BREIER, G., TSCHACHLER, E., ALBINI, A., and STURZL, M. (1996). Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am. J. Pathol. 149, 1851-1869.
40. ENSOLI, B., GENDELMAN, R., MARKJAM, P., FIORELLI, V., COLOMBINI, S., RAFFELD, M., CAFARO, A., CHANG, H.-K., BRADY, J.N., and GALLO, R.C. (1994). Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371, 674-680.
41. YANG, J., HAGAN, M.K., and OFFERMANN, M.K. (1994). Induction of IL-6 gene expression in Kaposi's sarcoma cells. J. Immunol. 152, 943-955.
42. BAIS, C., SANTOMASSO, B., COSO, O., ARVANTTAKIS, L., RAAKA, E.G., GUTKIN, J.S., ASCH, A.S., CESARMAN, E., GERHENGORN, M.C., and MESRI, E.A. (1998). G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391, 86-89.
43. BOSHOFF, C., ENDO, Y., COLLINS, P.D., TAKEUCHI, Y., REEVES, J.D., SCHWEICKART, V.L., SIANI, M.A., SASAKI, T., WILLIAMS, T J., GRAY, P.W., MOORE, P., CHANG, Y., and WEISS, R.A. (1997). Angiogenic and HlV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290-294.
44. SAID, J.V., CHIEN, K., TAKEUCHL S., TASAKA, T., ASOU, H., CHO, S.K., DE VOS, S., CESARMAN, E., KNOWLES, D.M., and KOEFFLER, H.P. (1996). Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood 87, 4937-4943.
45. PAZIN, G.J., ARMSTRONG, J.A., LAM, M.T., TARR, G.C., JANNETTA, P.J., and HO, M. (1979). Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N. Engl. J. Med. 301, 225-230.
46. MUNOZ, A., and CARRASCO, L. (1984). Formation of non-infective herpesvinis particles in cultured cells treated with human interferon. J. Gen. Viral. 65, 1069-1078.
47. NICHOLL, M.J., and PRESTON, C.M. (1996). Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific. J. Virol. 70, 6336-6339.
48. SINGH, A.K., SIDHU, G.S., FRIEDMAN, R.M., and MAHESHWARI, R.K. (1996). Mechanism of enhancement of the antiviral action of interferon against herpes simplex virus-1 by chloroquine. J. Interferon Cytokine Res. 16, 725-731.